DGAP-Adhoc: Cytos Biotechnology Ltd announces change in Executive Board

Cytos Biotechnology Ltd announces change in Executive Board

Schlieren (Zurich), Switzerland, October 27, 2014 - Cytos Biotechnology Ltd. (SIX:CYTN) ("Cytos" or the "Company") announced today that Mr. Matthias Alder, Executive Vice President Corporate Development and Legal Affairs, resigns from his function effective as of October 27, 2014.

The departure of Mr. Alder follows in the course of the winding down of key operational activities of the Company. Mr. Alder has agreed to continue his service to the Company as a consultant until February 28, 2015 to complete ongoing projects and facilitate the transition of his responsibilities.

For further information, please contact:

Cytos Biotechnology Ltd Harry Welten, MBA Chief Financial Officer Tel: +41 44 733 46 46 harry.welten@cytos.com

About Cytos Biotechnology Ltd

Cytos is a public biopharmaceutical company located in Schlieren (Zurich), Switzerland. The Company is listed according to the Main Standard on the SIX Swiss Exchange Ltd under the symbol CYTN.

Forward Looking Statements This media release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. You are urged to consider statements that include the words "will" or "expect" or the negative of those words or other similar words to be uncertain and forward-looking. Factors that may cause actual results to differ materially from any future results expressed or implied by any forward-looking statements include scientific, business, economic and financial factors, Against the background of these uncertainties, readers should not rely on forward-looking statements. The Company assumes no responsibility for updating forward-looking statements or adapting them to future events or developments.

http://www.cytos.com

+++++ Additional features: Document: http://n.equitystory.com/c/fncls.ssp?u=IERDRGWDVW Document title: Cchange in Executive Board

More:
DGAP-Adhoc: Cytos Biotechnology Ltd announces change in Executive Board